Abstract
Mouse CXCL14/BRAK is a monocyte-selective chemokine which is expressed in almost all normal tissues. A flood of reports on its new functions of tumor suppression and fat metabolism modulation has left CXCL14 a potential therapeutic candidate for these diseases. Therefore, a simple accessible method is on demand for large-scale production of recombinant mouse CXCL14 protein for in vivo animal studies. Here, we introduce an efficient method for large-scale production of recombinant mouse CXCL14, by which an 18-mg protein is produced from 2-L Escherichia coli culture with good bioactivity and low level of endotoxin.
Similar content being viewed by others
References
Meuter, S., & Moser, B. (2008). Cytokine, 44, 248–255.
Meuter, S., Schaerli, P., Roos, R. S., Brandau, O., Bosl, M. R., von Andrian, U. H., et al. (2007). Molecular and Cellular Biology, 27, 983–992.
Kurth, I., Willimann, K., Schaerli, P., Hunziker, T., Clark-Lewis, I., & Moser, B. (2001). The Journal of Experimental Medicine, 194, 855–861.
Shurin, G. V., Ferris, R. L., Tourkova, I. L., Perez, L., Lokshin, A., Balkir, L., et al. (2005). Journal of Immunology, 174, 5490–5498.
Starnes, T., Rasila, K. K., Robertson, M. J., Brahmi, Z., Dahl, R., Christopherson, K., et al. (2006). Experimental Hematology, 34, 1101–1105.
Schwarze, S. R., Luo, J., Isaacs, W. B., & Jarrard, D. F. (2005). The Prostate, 64, 67–74.
Nara, N., Nakayama, Y., Okamoto, S., Tamura, H., Kiyono, M., Muraoka, M., et al. (2007). The Journal of Biological Chemistry, 282, 30794–30803.
Ozawa, S., Kato, Y., Kubota, E., & Hata, R. (2009). Biomedical Research, 30, 315–318.
Pelicano, H., Lu, W., Zhou, Y., Zhang, W., Chen, Z., Hu, Y., et al. (2009). Cancer Research, 69, 2375–2383.
Sato, K., Ozawa, S., Izukuri, K., Kato, Y., & Hata, R. (2010). Cell Biology International, 34, 513–522.
Huising, M. O., Stet, R. J., Kruiswijk, C. P., Savelkoul, H. F., & Lidy Verburg-van Kemenade, B. M. (2003). Trends in Immunology, 24, 307–313.
Zhang, Z. H., Du, L. J., Xiang, D., Zhu, S. Y., Wu, M. Y., Lu, H. L., et al. (2009). Journal of Zhejiang University. Science B, 10, 79–86.
Chen, R. H., Huang, C. J., Newton, B. S., Ritter, G., Old, L. J., & Batt, C. A. (2009). Protein Expression and Purification, 64, 76–81.
Peterson, F. C., Thorpe, J. A., Harder, A. G., Volkman, B. F., & Schwarze, S. R. (2006). Journal of Molecular Biology, 363, 813–822.
Abraham, Z. H., & Symonds, N. (1990). The Biochemical Journal, 269, 679–684.
Hevehan, D. L., & De Bernardez Clark, E. (1997). Biotechnology and Bioengineering, 54, 221–230.
Sankar, S., & Porter, A. G. (1991). Journal of Virology, 65, 2993–3000.
Augsten, M., Hagglof, C., Olsson, E., Stolz, C., Tsagozis, P., Levchenko, T., et al. (2009). Proceedings of the National Academy of Sciences of the United States of America, 106, 3414–3419.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Li, J., Gao, J., Sah, S. et al. Expression and Purification of Bioactive High-Purity Recombinant Mouse CXCL14 in Escherichia coli . Appl Biochem Biotechnol 164, 1366–1375 (2011). https://doi.org/10.1007/s12010-011-9218-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-011-9218-y